Eurasian Patent Organization latest patents query
The latest invention patents collect the data information of Eurasian Patent Organization invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Antibody-resistant modified receptors to enhance cell-based therapy
ActiveEA054621B1
Owner:REGENERON PHARMACEUTICALS INC
Compositions and methods for post-translational modification in vivo
ActiveEA054684B1
Owner:THE WISTAR INST OF ANATOMY & BIOLOGY
VACCINES AGAINST RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS OF THEIR USE
ActiveEA054668B1
Owner:INOVIO PHARMACEUTICALS INC
SUBSTITUTED 6-(PYRIMIDINE-4-YL)QUINOLINE COMPOUNDS AS CYCLIN-DEPENDENT KINASE INHIBITORS
ActiveEA054671B1
Owner:BEONE MEDICINES I GMBH
PROTECTION DEVICE FOR PASSIVE FILLING PIPES OF THE MELT TRAP SHAFT
ActiveEA054640B1
Owner:JOINT CO ATOMENERGOPROEKT
CHIMERIC POLYPEPTIDE COMPLEX AND METHODS OF ITS PRODUCTION AND APPLICATION
ActiveEA054620B1
Owner:AMUNIX PHARMACEUTICALS INC
SYSTEM AND METHOD OF DIGITAL DESIGN OF INDUSTRIAL POLICY AND INSTITUTIONAL REFORMS
ActiveEA202691046A1
Owner:УЧРЕЖДЕНИЕ ОБРАЗОВАНИЯ АЛМАТЫ МЕНЕДЖМЕНТ УНИВЕРСИТЕТ
A DRUG SUBSTANCE AND A DRUG PRODUCT CONSISTENT WITH REMIBRUTINIB THAT ARE SUBSTANTIALLY FREE OF A NITROSAMINE CLASS IMPURITY
PendingEA202692368A1
Owner:NOVARTIS AG
METHOD OF ATTACHING THE SUPPORT TO THE BASE, FASTENING UNIT AND FASTENING SYSTEM
ActiveEA054632B1
Owner:ОЩЕПКОВА АЛЁНА АЛЕКСАНДРОВНА
SALT-TYPE GLP-1 RECEPTOR AGONIST, ITS CRYSTALLINE FORM, METHOD OF ITS PRODUCTION, ITS PHARMACEUTICAL COMPOSITION AND ITS APPLICATION
ActiveEA054682B1
Owner:HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
Engineered Meganucleases Specific to the Recognition Sequence in the Hepatitis B Virus Genome
PendingEA202691612A1
Owner:PRECISION BIOSCIENCES INC
THROMBIN-CLEAVABLE XTEN-CONTAINING LINKER AND ITS APPLICATIONS
ActiveEA054667B1
Owner:BIOVERATIV THERAPEUTICS INC
IL-18 RECEPTOR BETA (IL-18Rβ) TARGETED ANTIBODIES AND RELATED METHODS
PendingEA202692080A1
Owner:BRISTOL MYERS SQUIBB CO
Methods for treating cancer types and increasing the effectiveness of bisspecific BCMAxCD3 antibodies
ActiveEA054656B1
Owner:JANSSEN BIOTECH INC
DERIVATIVES OF BICYCLIC PHTHALAZINE-1(2H)-ONE AND THEIR APPLICATION
ActiveEA054661B1
Owner:NODTHERA LTD
Methods and compositions for the treatment of cardiopulmonary disorders
PendingEA202691308A1
Owner:ФАУНА БАЙО ИНКОРПОРЕЙТЕД
A COMPUTER-IMPLEMENTED METHOD AND SYSTEM FOR COMPARING TWO STRUCTURED LEGAL DOCUMENTS
ActiveEA202592542A1
Owner:OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU GRUPPA KOMPANII INNOTEKH
B2M-Targeted Genome Editing Compositions and Methods of Using Them
PendingEA202593244A1
Owner:ПРАЙМ МЕДИСИН ИНК
A METHOD FOR OBTAINING NETWORK INFORMATION REGARDING A PHYSICAL NETWORK PORT THAT IS REMOVED FROM THE CONTROL OF THE OPERATING SYSTEM KERNEL AND CONTROLLED BY AN APPLICATION IN USER SPACE
ActiveEA054647B1
Owner:OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU TEKHARGOS
2-(4-(2-(7,8-DIMETHYL-[1,2,4]TRIAZOLO[1,5-a]PYRIDINE-6-YL)-3-ISOPROPYL-1H-INDOL-5-YL)PIPERIDINE-1-YL)ACETAMIDE AND ITS CRYSTALLINE FORMS
PendingEA202690859A1
Owner:BRISTOL MYERS SQUIBB CO
ANGIOTENSIN II RECEPTOR ANTAGONIST AND ITS USE IN THE TREATMENT OF PERIPHERALLY INDUCED NEUROPATHIC PAIN
PendingEA202692313A1
Owner:БЭЙЦЗИН ТАЙД ФАРМАСЬЮТИКАЛ КО ЛТД
METHODS OF TREATMENT OF PULMONARY ARTERIAL HYPERTENSION WITH ACTIVIN RECEPTOR TYPE IIA (ActRIIA) PROTEINS AND / OR THEIR VARIANTS
PendingEA202691926A1
Owner:MERK SHARP I DOUM ELELSI
CATALYST FOR (CO)POLYMERIZATION OF OLEFINS, METHOD FOR ITS PRODUCTION AND METHOD FOR (CO)POLYMERIZATION OF OLEFINS
ActiveEA054641B1
Owner:PUBLIC JOINT STOCK COMPANY SIBUR HOLDING
Compositions and methods for treating muscle disorders
PendingEA202691297A1
Owner:KATE THERAPEUTICS INC
DOUBLE-CHAINED OLIGONUCLEOTIDE COMPOSITIONS FOR RNA INTERFERENCE AND RELATED METHODS
PendingEA202592277A1
Owner:UEJV LAJF SAENSIS LTD
Co-crystals, pharmaceutical compositions based on them and methods of treatment involving their use
ActiveEA054666B1
Owner:LES LAB SERVIER SA
Methods and kits for obtaining whole blood with inactivated pathogen
ActiveEA054649B1
Owner:CERUS CORP
Long-acting double peptide conjugates of GIP / GLP-1 and methods of use
ActiveEA054622B1
Owner:THE SCRIPPS RES INST
Compositions and methods for targeted delivery of TGFβ
ActiveEA054633B1
Owner:REGENERON PHARMACEUTICALS INC
LIGAND-DRUG CONJUGATES WITH IMPROVED PHARMACOKINETIC AND DRUG RELEASE PROPERTIES
ActiveEA054670B1
Owner:DEBIOPHARM RESEARCH & MANUFACTURING SA
A METHOD FOR THE (CO)POLYMERIZATION OF ETHYLENE WITH ALPHA-OLEFIN USING A CATALYTIC SYSTEM CONTAINING CHROMIUM AND ALUMINUM
ActiveEA054643B1
Owner:PUBLIC JOINT STOCK COMPANY SIBUR HOLDING
METHOD FOR PREPARING A LIQUID PHOSPHATE COMPOSITION AND METHOD FOR PREPARING A DICALCIUM PHOSPHATE COMPOSITION
ActiveEA054675B1
Owner:PRAYON SA
Engineered Antibodies as Molecular Destructors via Cellular Receptors
ActiveEA054626B1
Owner:JEJL JUNIVERSITI
Methods for obtaining selective destructors of estrogen receptors
ActiveEA054654B1
Owner:EHLI LILLI EHND KOMPANI
EFFICIENT SYNTHESIS OF β-L-5-[((E)-2-BROMOVINYL)-1-((2S,4S)-2-(HYDROXYMETHYL)-1,3-(DIOXOLAN-4-YL)URACIL)] (L-BHDU) USING CHIRALLY PURE L-DIOXOLANE
PendingEA202692328A1
Owner:UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC
Combination of antibody-drug conjugate with anti-SIRPα antibody
ActiveEA054652B1
Owner:DAIICHI SANKYO CO LTD
Formulations containing variants of Actria polypeptide
PendingEA202692210A1
Owner:MERK SHARP I DOUM ELELSI
A METHOD FOR OBTAINING NETWORK INFORMATION REGARDING A PHYSICAL NETWORK PORT THAT IS REMOVED FROM THE CONTROL OF THE OPERATING SYSTEM KERNEL AND CONTROLLED BY AN APPLICATION IN USER SPACE
ActiveEA202593532A1
Owner:OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU TEKHARGOS
TREATMENT OF MUSCLE-RELATED DISORDERS WITH HUMAN CACNG1 ANTIBODIES
ActiveEA054672B1
Owner:REGENERON PHARMACEUTICALS INC
NEW SYNTHESIS STEPS FOR A METHOD FOR PRODUCING THE PDE4B INHIBITOR 1-[({(5R)-2-[4-(5-CHLOROPYRIMIDINE-2-YL)PIPERIDINE-1-YL]-5-OXIDO-6,7-DIHYDROTHIENO[3,2-d]PYRIMIDINE-4-YL}AMINO)CYCLOBUTYL]METHANOL
PendingEA202692027A1
Owner:BOEHRINGER INGELHEIM INT GMBH
LONG-ACTING INTERLEUKIN-15 RECEPTOR AGONISTS AND RELATED IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS
ActiveEA054635B1
Owner:NEKTAR THERAPEUTICS INC
PROTEASOME COMPLEX INHIBITORS TARGETING CLPP1P2 PROTEASE
ActiveEA054678B1
Owner:THE GLOBAL ALLIANCE FOR TB DRUG DEV
A METHOD FOR MANUFACTURING ONE OR MORE LAMINATED BOARDS AND A LAMINATED BOARD
ActiveEA054645B1
Owner:KRONOPLUS LTD
PEPTIDIC ACIDS AS GLP1R AGONISTS AND THEIR ANTIBODY-DRUG CONJUGATES
PendingEA202691549A1
Owner:REGENERON PHARMACEUTICALS INC
TEMPERATURE-CONTROLLED TRANSPORT CONTAINER AND TRANSPORTATION METHOD
ActiveEA054638B1
Owner:COLDEST CHAIN OY
Fused proteins containing acid alpha-glucosidase enzymes and methods for their production
PendingEA202691711A1
Owner:DENALI THERAPEUTICS INC
TRANSCATHETER EXPANSIVE SYSTEM, METHOD OF MANUFACTURING THIS SYSTEM AND METHOD OF ITS IMPLANTATION
ActiveEA054687B1
Owner:RENATA MEDICAL INC
Subcutaneous Administration and Dosage of Anti-C5 Antibodies for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
ActiveEA054677B1
Owner:ALEXION PHARMACEUTICALS INC
ARRANGEMENT FOR INSTALLING A CEMENT BRIDGE THROUGH A WHINKLE WEDGE
PendingEA202592533A1
Owner:САЛАЕВ МИРСАЛЕХ ТАМЕРЛАН ОГЛЫ +3
METHOD FOR SYNTHESIS OF METHANOL WITH OPTIMIZED PREPARATION AND PROCESSING OF SYNTHESIS GAS
ActiveEA054648B1
Owner:DZHONSON METTEJ DEJVI TEKNOLODZHIZ LTD
METHOD OF ECOTHERAPY AND ECOLOGICAL REHABILITATION
ActiveEA202690561A1
Owner:ШЕВЦОВ СЕРГЕЙ АЛЕКСАНДРОВИЧ
INHIBITOR WHICH IS A NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, A METHOD FOR ITS PRODUCTION AND ITS APPLICATION
ActiveEA054686B1
Owner:SHANGHAI HANSOH BIOMEDICAL CO LTD +1
CONCRETE DRAINAGE TRAY
PendingEA202591762A1
Owner:ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ САПА СУ
7-AZA-BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 1 INHIBITORS
PendingEA202691431A1
Owner:РИБОСАЙЕНС ЛЛС
6- AND 5-HETERARYL DERIVATIVES AND THEIR APPLICATIONS
PendingEA202691670A1
Owner:CMS RESEARCH & DEVELOPMENT PTE LTD